ライフサイエンスコーパス: benign disease

1 hyroidectomy, 47% had thyroid cancer and 53% benign disease.

2 a (AEC > 1500/muL) appear to have clinically benign disease.

3 esection for colon cancer approached that of benign disease.

4 table mRNA and benign thyroid sonography had benign disease.

5 screening results and biopsies performed for benign disease.

6 ade (>/=GS7) from low-grade (GS6) cancer and benign disease.

7 d the number of women undergoing surgery for benign disease.

8 this patient subset, many will prove to have benign disease.

9 negative control subjects undergoing EUS for benign disease.

10 hyroidectomy, 47% had thyroid cancer and 53% benign disease.

11 hepatic or biliary cancers and 161 (9%) for benign disease.

12 lymph nodes obtained from nine patients with benign disease.

13 ) and 32 lymph nodes from nine patients with benign disease.

14 ts with hepatic malignancies from those with benign disease.

15 (n = 63) were women whose biopsies revealed benign disease.

16 nd the United States, varicella is usually a benign disease.

17 ginal carcinoma after total hysterectomy for benign disease.

18 eening in women after total hysterectomy for benign disease.

19 m healthy individuals and from patients with benign diseases.

20 that for the women who learned that they had benign disease (-0.154 ln [microg/dL]/hr; 95% CI: -0.197

21 omen also underwent one or more biopsies for benign disease (11.3%, 26.3%, and 30.3%, respectively).

22 s (27.2%) compared with patients treated for benign disease (14.1%) (P < .001).

23 ening recommendations after hysterectomy for benign disease, (2) total hysterectomy for benign diseas

24 nd 944 from 1998 to 2006 (group II), 24% for benign disease, 76%, cancer.

25 Benign disease accounted for the majority of operations

26 Of these, 10 had benign disease and 4 had cancer, 3 on the ipsilateral si

27 THE was performed in 1085 patients, 26% with benign disease and 74% with cancer.

28 ncerous benign disease depend on the type of benign disease and cancer grade.

29 y was performed in 1344 patients (78.4%) for benign disease and in 371 patients (21.6%) for malignant

30 In one patient with benign disease and in one patient with malignant feature

31 that endoscopic therapy may be successful in benign disease and should be considered prior to surgica

32 alization biopsy (group I) or by documenting benign disease and sparing the patient needle localizati

33 a on the risk between total hysterectomy for benign disease and subsequent vaginal carcinoma were org

34 ical cancer-they underwent the procedure for benign disease and they no longer have a cervix.

35 cement in children is almost always done for benign disease and thus requires a conduit that will las

36 static prostate cancer compared with that of benign diseases and healthy adults.

37 erpretation errors, the CT findings mimicked benign disease, and the patients also had underlying lun

38 ip expression profiles of 4400 human normal, benign, diseased, and tumor samples from >60 tissue type

39 r benign disease, (2) total hysterectomy for benign disease as a risk for vaginal dysplasia or carcin

40 imination between GS7 or greater and GS6 and benign disease: AUC 0.77 (95% CI, 0.71-0.83) vs SOC AUC

41 ideal procedure for patients with end-stage benign disease, Barrett's esophagus with high-grade dysp

42 have improved the diagnosis and treatment of benign disease but have not significantly increased our

43 ovarian cancer (EOC) was confirmed and from benign disease cases randomly selected from the remainin

44 e treatment escalation and those with a more benign disease course.

45 scriminate prostate cancer from noncancerous benign disease depend on the type of benign disease and

46 survival rates--but also spare patients with benign disease from undergoing unnecessary surgery.

47 was also lower than in gallstone plus other benign disease group (p < 0.05).

48 he cause was underlying malignancy in 43 and benign disease in 16.

49 tric cancer, gastric outlet obstruction, and benign disease.In the area of upper gastrointestinal tra

50 Laparoscopic colectomy for benign disease increased from 6.2% in 2001-2003 to 11.8%

51 V) infection in humans range from the fairly benign disease infectious mononucleosis to life-threaten

52 Historically seen as a benign disease, it is now becoming clear that Plasmodium

53 gnant group), and patients who knew they had benign disease (known benign group).

54 in age distribution among the patients with benign disease, lung cancer, and metastasis, although no

55 Among 13 patients with benign disease (mean follow-up, 17.0 months; range, 1-27

56 KV has previously been known as a relatively benign disease, more recent epidemic events have brought

57 n = 418) and in patients monitored for known benign disease (n = 151).

58 Current selection factors for MIDP were benign disease (odds ratio: OR: 1.56, CI: 1.10-2.21) and

59 evolved, resulting in wider applications in benign disease of the esophagus, biliary tree, and pancr

60 The care of benign disease of the stomach and duodenum is also evolv

61 increasing numbers for various malignant and benign diseases of the pancreas and periampullary region

62 t years to resect a variety of malignant and benign diseases of the pancreas and periampullary region

63 ers (n = 38), and outpatients attending with benign diseases of the urogenital tract (n = 20) were us

64 iscrimination of GS7 or greater from GS6 and benign disease on initial biopsy.

65 ith colorectal cancer, and 125 subjects with benign disease or other types of cancer were evaluated.

66 from leukocytes and mammary tissue (normal, benign diseases, or malignant tumors) from 87 women with

67 subgrouped into chronic pancreatitis, other benign disease, pancreatic adenocarcinoma, and other can

68 olated hematuria or isolated proteinuria had benign disease processes.

69 (76.2%) patients had surgery for cancer and benign disease, respectively.

70 e cancer samples were distinguished from the benign disease samples with a 95% and 92% sensitivity an

71 oided in 31 patients: 17 of 20 patients with benign disease, seven patients with metastatic disease,

72 t least 20 years postpartial gastrectomy for benign disease should be considered for annual endoscopi

73 for well-differentiated thyroid carcinoma or benign disease should be transplanted in the sternocleid

74 cedure is used more widely, for instance, in benign diseases such as chronic pancreatitis.

75 rthritis is decreasing and that it is a more benign disease than previously recognized.

76 these enzymes in lesions of endometriosis, a benign disease that presents as persistent ectopic sites

77 In contrast, for benign disease, the OR was 2.10 (confidence interval 1.7

78 ginal carcinoma after total hysterectomy for benign disease, though the best-designed research sugges

79 CC, 11 healthy controls, and 9 patients with benign diseases to test the models, sensitivities and sp

80 Current selection factors for ODP or MIDP (benign disease, tumor size, and BMI) do not mitigate the

81 (ERCP) in 59 patients with gallstone, other benign disease, tumour, and primary sclerosing cholangit

82 disease was diagnosed in nine patients, and benign disease was diagnosed in three.

83 Patients undergoing thyroidectomy for benign disease were allocated by a block randomized list

84 wed in 18 patients (17 with cancer, one with benign disease) who had tubular retrocrural structures o

85 Although NASH is most often a benign disease with an indolent course, patients with th

86 DCIS was not consistently distinguished from benign disease with any method.